# Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study

> **NCT07381556** · PHASE4 · RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 50 (estimated)

## Conditions studied

- Alopecia Areata(AA)
- Alopecia Areata (AA)
- Alopecia Totalis/Universalis
- Alopecia Universalis (AU)
- Alopecia Totalis (AT)
- Alopecia Areata (& Ophiasis)

## Interventions

- **DRUG:** Methotrexate
- **DRUG:** Cyclosporin (CSA)

## Key facts

- **NCT ID:** NCT07381556
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07381556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07381556, "Cyclosporine Or Methotrexate for Pediatric Alopecia Areata: Routine Clinical Care Effectiveness Study". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07381556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*